Skip to main content
Tag

commercialization Archives - BioHealth Innovation

The Top 5 Reasons You Should Be Part of the 12th Annual BioHealth Capital Region Week

By News

BioHealth Capital Region Week returns September 15–17, 2026, at US Pharmacopeia in Rockville, Maryland, bringing together leaders from across industry, academia, government, investment, research institutions, economic development, and entrepreneurship.

This year’s theme, “Growing the BioHealth Capital Region of Tomorrow,” reflects a practical question facing the region: How do we turn our scientific assets, federal presence, talent, infrastructure, and industry base into more companies, stronger partnerships, greater investment, and sustained economic growth?

BHCR Week creates three distinct opportunities to take part in that work: the BioHealth Capital Region Forum, the Crab Trap Competition, and the BioHealth Capital Region Investment Conference. Each serves a different audience and purpose, but together they span the full path from ideas and research to company formation, commercialization, financing, and growth.

1. The region’s full biohealth ecosystem will be in one place

BHCR Week is one of the few events where executives, founders, researchers, investors, government leaders, economic development organizations, universities, health institutions, and professional service partners come together around the same regional agenda.

Each year, the event draws hundreds of attendees representing biotech, biopharma, medtech, digital health, academic and research institutions, investment organizations, government agencies, economic development groups, and companies that provide legal, financial, technical, real estate, consulting, and commercialization support.

That mix matters. Most companies do not grow through one relationship or one source of support. They need capital, talent, facilities, regulatory guidance, research partnerships, service providers, customers, and a network that can help them move from one milestone to the next.

BHCR Week gives attendees access to many of those relationships in one place. A founder can meet an investor, an economic development leader, a university partner, and a potential service provider during the same week. An established company can connect with emerging technologies, regional decision-makers, and potential collaborators. Investors can see both the companies seeking capital and the institutions helping create the next generation of opportunities.

2. The program is focused on the issues shaping the region’s next decade

The 2026 program looks beyond a single trend or industry challenge. It will examine the combination of technologies, resources, policies, and partnerships needed for the BioHealth Capital Region to continue growing.

The Forum will include conversations around AI and quantum applications in biohealth, commercialization, financing, economic development, infrastructure, manufacturing, standards, supply chains, workforce, dual-use technologies, company formation, and regional collaboration.

These subjects are connected. Companies need access to capital, but they also need the physical and digital infrastructure to operate. Research institutions need commercialization pathways and experienced leadership. Emerging technologies need practical use cases, trusted standards, and partners capable of moving them into the market. The region must also understand why companies choose to start, remain, expand, or relocate here.

The Forum is designed to bring those conversations together rather than treating them as separate issues. Attendees will hear from leaders who are working on these challenges from different perspectives and have opportunities to connect those ideas to their own organizations.

3. Three different events create three different ways to participate

BioHealth Capital Region Week is not a single-format conference. Its three events are designed for different stages of the innovation and company-growth process.

BioHealth Capital Region Forum

September 15–16, 2026

The Forum is the thought-leadership and regional-convening portion of BHCR Week. Across two days, attendees will hear keynotes, panel discussions, regional updates, and conversations focused on the future of the biohealth ecosystem.

The Forum is a strong fit for company leaders, researchers, entrepreneurs, academic institutions, government agencies, economic development organizations, investors, professional service firms, and anyone working to strengthen the regional life sciences economy.

Attendees should register if they want to understand what is changing across the region, meet decision-makers from multiple sectors, discover potential partners, and take part in conversations about how the BioHealth Capital Region grows from here.

Registration is free thanks to sponsors, but advance registration is required:

https://eventmobi.com/website/BHCR2026

Crab Trap Competition

September 16, 2026

The Crab Trap Competition gives emerging biohealth companies an opportunity to pitch live before investors, judges, industry leaders, and regional partners.

Selected finalists gain more than stage time. They receive visibility across the regional ecosystem, direct feedback, and opportunities to build relationships with people who may be able to support their next stage of development.

The current prize package includes $15,000 in cash and more than $20,000 in professional services, with additional prizes still being added. Those services can be especially valuable for early-stage companies that need specialized support but may not yet have the budget or internal capacity to secure it.

Companies working across biotech, medtech, diagnostics, digital health, AI-enabled health, and other areas of life sciences should apply if they are ready to raise their visibility, sharpen their story, connect with investors and partners, and compete for resources that can help them move forward.

Apply for the 2026 Crab Trap Competition here:

https://bit.ly/CrabTrap2026

BioHealth Capital Region Investment Conference

September 17, 2026

The Investment Conference is a full day focused on connecting companies with capital, strategic partners, economic development leaders, and regional resources.

Emerging and growth-stage companies can meet investors and organizations that understand the life sciences development cycle. Investors can gain exposure to promising companies and technologies across biotech, biopharma, medtech, digital health, AI-enabled biohealth, and related fields.

The conference is also valuable for technology transfer leaders, accelerators, research institutions, service providers, and economic development organizations that help companies become more investable and connect with the resources needed to scale.

Companies should register if they are seeking funding, partnerships, strategic guidance, or greater visibility with the investment community. Investors should attend to identify new opportunities, meet company leaders, and gain a clearer view of the innovation pipeline emerging from the BioHealth Capital Region and beyond.

Investment Conference registration is separate from Forum registration:

https://eventmobi.com/website/BHCR2026/investment-conference

Attendees interested in both events must complete both registrations.

4. BHCR Week is built to create connections that can lead to action

The value of BHCR Week is not limited to what happens on stage. Much of the event’s value comes from the conversations between sessions, introductions made through regional partners, and follow-up discussions that continue after the week ends.

For an early-stage company, one introduction could lead to a future investor conversation, pilot opportunity, service relationship, or research partnership. For an established company, the week can provide access to new technologies, talent, policy perspectives, and regional resources. For an investor, it offers a chance to meet both companies and the institutions supporting their development.

The three-event structure helps create those connections across different settings. The Forum establishes shared context around regional priorities. Crab Trap puts emerging companies and technologies in front of the community. The Investment Conference creates a more direct environment for conversations around capital, company readiness, and growth.

That combination makes BHCR Week more than an annual gathering. It is a platform for turning regional relationships into tangible opportunities.

5. BHCR Week is free to attend thanks to sponsors

Many major industry events come with registration fees that can limit who is able to participate. BHCR Week takes a different approach.

Sponsor support allows the Forum and Investment Conference to remain free to attend. That removes a financial barrier for entrepreneurs, researchers, students, emerging companies, investors, public-sector partners, and others who should be part of the conversation.

Free registration also strengthens the event itself. It creates room for a wider range of organizations, career levels, and perspectives. It allows smaller companies and institutions to participate alongside major corporations, government agencies, universities, and established investors.

Sponsors make that access possible while gaining visibility across the Forum, Crab Trap Competition, Investment Conference, and VIP Leadership Dinner. Their support helps create a stronger audience, more productive connections, and a more accessible platform for the region.

Be Part of BHCR Week 2026

The BioHealth Capital Region has the research, companies, institutions, talent, federal assets, and infrastructure to remain one of the country’s leading life sciences ecosystems. Continuing that momentum requires the right people to come together, understand what is changing, and build the partnerships needed for the next stage of growth.

Register for the BioHealth Capital Region Forum:

https://eventmobi.com/website/BHCR2026

Register separately for the BioHealth Capital Region Investment Conference:

https://eventmobi.com/website/BHCR2026/investment-conference

Apply for the Crab Trap Competition:

https://bit.ly/CrabTrap2026

Organizations can also support the week as sponsors. Sponsorship helps keep the Forum and Investment Conference free to attend while giving companies, institutions, and regional partners visibility across the full week. Sponsors are also invited to the VIP Leadership Dinner, which provides a more focused setting to connect with senior executives, investors, speakers, and regional leaders.

To learn more about sponsorship opportunities, contact:

Rich Bendis at rbendis@biohealthinnovation.org and Andy Eckert at aeckert@biohealthinnovation.org.

BioHealth Capital Region Week takes place September 15–17, 2026, at US Pharmacopeia in Rockville, Maryland.

BHI EIR Insights: 7 Tactics to Optimize Launch Messaging – Part I

By EIR Insights, News

by Jonathan Kay, MPP, Managing Partner, Health Market Experts & BioHealth Innovation, Inc. Entrepreneur-in-Residence

Healthcare is complicated. Communicating effectively doesn’t need to be.

For a new medical technology, biologic, pharmaceutical, or digital health solution, a critical element of go-to-market strategy (GTM) and initial commercial success is messaging.

But messaging often doesn’t get the attention it deserves.

GTM messaging could include messages to any: physicians, hospital administrators, policy makers, patients, caregivers, payers, and more.

This post kicks off our 7-part series on Optimizing Launch Messaging 🚀, where we will share 7 valuable tactics to help achieve your goals related to access, commercial success, and improved patient outcomes.

Tactic 1: Test, Don’t Guess

The first step to optimizing launch strategy is embracing a data-driven mindset:

Healthcare markets are complex in so many ways. Think of the scientific, clinical, regulatory, reimbursement, and competitive landscape. Testing in a complex and changing environment helps minimize risk and maximize potential.

Companies run clinical trials to test the impact of a therapy. Similarly, commercial teams should test their launch communications to ensure they are effective and safe. That is, are the messages clear, credible, and persuasive? Do the messages avoid unintended consequences?

Why test messages? We test messages to:

  • Understand unmet needs
  • Assess competitive differentiators
  • Understand which messages resonate and why
  • Learn how to motivate appropriate behavior

Do you have a positive example from when you tested messages in advance of using them? Share your thoughts below!

At Health Market Experts, we make corporate and brand messaging more efficient and effective. If your organization is preparing to launch a product or a campaign, connect with us to learn more about how we can help you develop and execute your launch plan and maximize success. Ask us about message awareness and attribution, too.

This post was written with NI not AI (written by a human using natural intelligence).

This post expands on content I previously wrote as a blog at Catalant and delivered in guest lectures at Rutgers Business School.

Visit https://www.linkedin.com/in/jonathan-kay-healthcare/ to connect with Jon on LinkedIn.

TEDCO’s Maryland Innovation Initiative Announces First Round of Baltimore Innovation Initiative Awardees

By News

The Baltimore Innovation Initiative awards a total of more than $645,000 to 14 awardees

COLUMBIA, Md., (August 18, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced the first round of the Baltimore Innovation Initiative (BII) Pilot Program awardees, marking an important milestone for the organization. The BII Pilot Program falls under the Maryland Innovation Initiative (MII), fueling innovation and economic impact in the Baltimore region.

“The first round of BII awardees exemplify the innovation present throughout the Baltimore-Columbia-Towson Metropolitan Statistical Area,” said Abi Kulshreshtha, executive director, MII. “These awards will advance innovative technologies from seven colleges and universities, contributing to Maryland’s growing innovation ecosystem.”

The BII was created to support an equitable innovation and entrepreneurial ecosystem within higher education institutions in the Baltimore-Columbia-Towson Metropolitan Statistical Area (MSA). As part of Maryland’s matching contribution toward the Baltimore Tech Hub, the BII seeks to advance technology toward commercialization of a product or service and bolster support for entrepreneurs developing technology-based ventures.

“We received a number of excellent candidates – choosing the 14 awardees was a difficult process, but we feel these awardees are best positioned to utilize the funding provided to progress towards commercialization,” said Jalaycia Lewis, BII program manager.

The Technology Advancement Grant offers applicants support to commercialize a new or existing technology at an eligible institution while the Entrepreneurship and Commercialization Programming and Infrastructure Grant supports the creation or enhancement of entrepreneurship programs and commercialization infrastructure for technology-based ventures.

The eight Technology Advancement awardees include:

  1. Selena Shirkin,Fetal Therapy Technologies: Designing a novel port system for microsurgery; Johns Hopkins University
  2. Rebecca Greene,Semiautonomous Humanistic Algorithm for Reduced Effort and Enhanced Dexterity (SHARE2D) Control; Johns Hopkins University
  3. Anika Mistry,DevMinds: adaptive social-emotional learning to support neurodiverse kids beyond therapy sessions; Johns Hopkins University
  4. Oriol Cuxart,A breakthrough neuromodulation solution for Chronic Rhinosinusitis patients; Johns Hopkins University
  5. Michael Tangrea, advancing precision medicine through commercialization of the micropurification technology; Loyola University Maryland
  6. Kevin Tu, developing a secure and integrated fume hood management platform to reduce energy waste in research laboratories; University of Maryland, Baltimore
  7. Andres Londoño,DegreeMap: A smart degree planning platform for Maryland higher education; Towson University
  8. Debbie Sahlin, ACCESS-DP Advancing Coordinated Care and Emerging Smart Solutions for Disabled Populations; University of Maryland, Baltimore

The six Entrepreneurship Commercialization, Programming and Infrastructure Awardees include:

  1. Ian Ryu,AI Venture Studio Pilot; Johns Hopkins University
  2. Wendy Bolger, Support for the Baltipreneurs Accelerator; Loyola University Maryland
  3. Ryan Hoover, Launching the MICA Biodesign Program to Support and Diversify the Regional Bioeconomy; Maryland Institute College of Art
  4. Henry Mortimer,UBalt AI-Enabled Business Incubator; University of Baltimore
  5. Kenneth Wong,Center for Climate and Health Entrepreneurship; University of Maryland, Baltimore
  6. Jamie Gurganus,Embedding Entrepreneurial Mindset in Academia: Launching the Entrepreneurial Learning Lab at UMBC; University of Maryland, Baltimore County

“Innovative entrepreneurs thrive in Maryland with the support of programs like BII,” said TEDCO CEO, Troy LeMaile-Stovall. “As the number one state for minority-owned businesses, Maryland is moving the needle forward. By embracing diversity, we continue to see growth in a merit-based ecosystem that will not only bring the state to the forefront of innovation but will allow for sustainability.”

The MII was established as a collaboration between the State of Maryland and five academic research institutions, and leverages each institution’s strengths while promoting the commercialization of research conducted there. Since its inception, the program has invested more than $59 million in promising research commercialization, supported nearly 200 companies and generated almost 400 jobs. The success of the MII led to several pilot programs that expanded MII’s reach to two more comprehensive universities in addition to the creation of BII.

To learn more about the MII and BII programs, eligibility and application details, visit tedcomd.com/funding/maryland-innovation-initiative.

About TEDCO

TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.

###

Media Contact

Tammi Thomas, Chief Development & Marketing Officer, TEDCO, tthomas@tedcomd.com

Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.